3595 related articles for article (PubMed ID: 12618755)
21. 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
Shen SC; Ko CH; Hsu KC; Chen YC
Int J Cancer; 2004 Feb; 108(4):502-10. PubMed ID: 14696113
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathways.
Kamiguti AS; Harris RJ; Slupsky JR; Baker PK; Cawley JC; Zuzel M
Oncogene; 2003 Apr; 22(15):2272-84. PubMed ID: 12700663
[TBL] [Abstract][Full Text] [Related]
23. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
[TBL] [Abstract][Full Text] [Related]
24. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
25. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
[TBL] [Abstract][Full Text] [Related]
26. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
27. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
Wang Z; Jiang C; Ganther H; Lü J
Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
[TBL] [Abstract][Full Text] [Related]
28. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor alpha-resistant ovarian carcinoma cell line UCI 101.
Yazlovitskaya EM; Pelling JC; Persons DL
Mol Carcinog; 1999 May; 25(1):14-20. PubMed ID: 10331740
[TBL] [Abstract][Full Text] [Related]
29. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
[TBL] [Abstract][Full Text] [Related]
30. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
Chuang SM; Wang IC; Yang JL
Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
[TBL] [Abstract][Full Text] [Related]
31. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.
Singh RP; Tyagi AK; Zhao J; Agarwal R
Carcinogenesis; 2002 Mar; 23(3):499-510. PubMed ID: 11895866
[TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Leu CM; Chang C; Hu C
Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
[TBL] [Abstract][Full Text] [Related]
33. Mitogenic synergy through multilevel convergence of hepatocyte growth factor and interleukin-4 signaling pathways.
Day RM; Soon L; Breckenridge D; Bridges B; Patel BK; Wang LM; Corey SJ; Bottaro DP
Oncogene; 2002 Mar; 21(14):2201-11. PubMed ID: 11948403
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of NF-kappaB pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells.
Dhanalakshmi S; Agarwal R; Agarwal C
Int J Oncol; 2003 Sep; 23(3):721-7. PubMed ID: 12888909
[TBL] [Abstract][Full Text] [Related]
35. Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin-induced apoptosis of human lung adenocarcinoma cells.
Zhao Y; You H; Yang Y; Wei L; Zhang X; Yao L; Fan D; Yu Q
J Cell Biochem; 2004 Feb; 91(3):621-32. PubMed ID: 14755690
[TBL] [Abstract][Full Text] [Related]
36. Phosphorylation of mitogen-activated protein kinase is inhibited by calcitonin in DU145 prostate cancer cells.
Segawa N; Nakamura M; Nakamura Y; Mori I; Katsuoka Y; Kakudo K
Cancer Res; 2001 Aug; 61(16):6060-3. PubMed ID: 11507054
[TBL] [Abstract][Full Text] [Related]
37. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
[TBL] [Abstract][Full Text] [Related]
38. Cholecystokinin stimulates extracellular signal-regulated kinase through activation of the epidermal growth factor receptor, Yes, and protein kinase C. Signal amplification at the level of Raf by activation of protein kinase Cepsilon.
Piiper A; Elez R; You SJ; Kronenberger B; Loitsch S; Roche S; Zeuzem S
J Biol Chem; 2003 Feb; 278(9):7065-72. PubMed ID: 12496267
[TBL] [Abstract][Full Text] [Related]
39. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
40. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
Pearson LL; Castle BE; Kehry MR
Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
